ANGELA BETTERS: Open Payments
NPI 1295442325 · SALEM, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 32 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $324 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $152 |
| Alkermes, Inc. | 6 | $142 |
| Neurocrine BioSciences, Inc. | 5 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $76 |
| Collegium Pharmaceutical, Inc. | 4 | $71 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Lundbeck LLC | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: VRAYLAR, ARISTADA, INGREZZA, CAPLYTA, Jornay PM, REXULTI, INVEGA SUSTENNA, Auvelity.
Industry payments across IL — which companies pay providers there.
